Composition:
Solvex syrup:
Each teaspoonful (5ml) contains:
Carboxymethyl cysteine ……………….. 250 mg

Solvex capsules:
Each capsule contains:
Carboxymethyl cysteine ……………….. 375 mg

Properties:
Carboxymethyl cysteine is a systemically active mucolytic agent that achieves a high blood level concentration after oral administration.
It acts by:
► Attaching the disulfide bonds of the thick mucous fibers to cause the complete
    fragmentation.
► Reducing the viscosity of the mucin secreted by the respiratory mucosa. It also protects the mucous membrane against
    irritation of inhaled gases.

Indications:
All cases associated with excessive viscous sputum, such as:
► Pneumoconiosis
► Chronic bronchitis
► Tracheobronchitis
► Emphysema

Contraindications:
Peptic ulcer.
N.B.:
Patients should be expecting an increase of excretion flow.
Safety has not been determined during the first trimester of pregnancy.

Over dose:
Gastric lavage may be beneficial, followed by observation.
Treatment symptoms: GIT disturbance.

Dosage & route of administration & duration:
Adults including the elderly ……………… 750 mg, 3 times daily and reduced to one capsule daily when a response is obtained.
Children:
2-5 years ……………………. 62.5-125 mg, 4 times daily.
6-12 years ………………….. 250 mg, 3 times daily.

Incompatibility:
Mixture of pholcodeine linctus may cause precipitation of carbocysteine from the solution.

Side effects:
Gastro-intestinal symptoms such as nausea, diarrhea or GIT (Gastro-intestinal tract disturbance) bleeding and skin rash may occur.

Storage:
Protect from light and the temperature not exceeding 30°C.
Keep medicine out of reach of children.

Presentation:
Syrup: bottle of 60 and 120 ml.
Capsules: box of 20 capsules.